Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Vermilion Energy
VET
$1.73B
| $972K | ﹤0.01% |
80,622
+44,800
| +125% | +$593K |
|
2427
Apyx Medical
APYX
$128M
| $971K | ﹤0.01% |
370,503
-33,904
| -8% | -$82.1K |
|
2428
Lifetime Brands
LCUT
$226M
| $970K | ﹤0.01% |
144,551
-26,749
| -16% | -$156K |
|
2429
Myomo
MYO
$68.1M
| $970K | ﹤0.01% |
193,600
+145,400
| +302% | +$387K |
|
2430
Mastech Digital
MHH
$94.7M
| $969K | ﹤0.01% |
115,027
-700
| -0.6% | -$6.06K |
|
2431
Pacer Trendpilot US Large Cap ETF
PTLC
$3.38B
| $969K | ﹤0.01% |
22,405
+1,205
| +6% | +$49.6K |
|
2432
MarketWise
MKTW
$54.2M
| $967K | ﹤0.01% |
17,715
+9,980
| +129% | +$488K |
|
2433
Horizon Bancorp
HBNC
$1.06B
| $962K | ﹤0.01% |
67,216
-23,400
| -26% | -$264K |
|
2434
Perimeter Solutions
PRM
$5.55B
| $961K | ﹤0.01% |
209,000
-246,541
| -54% | -$947K |
|
|
GOL
2435
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $961K | ﹤0.01% |
265,500
-47,600
| -15% | -$157K |
|
2436
Janus Henderson Mortgage-Backed Securities ETF
JMBS
$6.75B
| $960K | ﹤0.01% |
20,900
-16,400
| -44% | -$718K |
|
2437
Vanguard Consumer Staples ETF
VDC
$8.04B
| $955K | ﹤0.01% |
+5,000
| New | +$917K |
|
2438
Hyliion Holdings
HYLN
$725M
| $953K | ﹤0.01% |
1,171,300
-57,800
| -5% | -$41K |
|
2439
UMB Financial
UMBF
$11.5B
| $952K | ﹤0.01% |
11,400
-117,700
| -91% | -$8.28M |
|
2440
Agios Pharmaceuticals
AGIO
$2B
| $951K | ﹤0.01% |
+42,714
| New | +$957K |
|
|
TIGR
2441
UP Fintech Holding
TIGR
$822M
| $951K | ﹤0.01% |
215,184
+50,608
| +31% | +$233K |
|
2442
Precision BioSciences
DTIL
$205M
| $946K | ﹤0.01% |
86,374
+33,305
| +63% | +$359K |
|
|
SHYF
2443
DELISTED
The Shyft Group
SHYF
| $946K | ﹤0.01% |
77,448
-13,800
| -15% | -$169K |
|
2444
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.84B
| $945K | ﹤0.01% |
14,200
-5,700
| -29% | -$366K |
|
2445
NLI Holdings
NL
$315M
| $945K | ﹤0.01% |
168,361
+14,759
| +10% | +$74K |
|
|
UDMY
2446
DELISTED
Udemy
UDMY
| $938K | ﹤0.01% |
+63,700
| New | +$793K |
|
2447
CVB Financial
CVBF
$4.09B
| $937K | ﹤0.01% |
46,394
-101,525
| -69% | -$1.8M |
|
|
QVCGA
2448
DELISTED
QVC Group Inc Series A
QVCGA
| $932K | ﹤0.01% |
21,281
-40,829
| -66% | -$1.4M |
|
|
INZY
2449
DELISTED
Inozyme Pharma
INZY
| $931K | ﹤0.01% |
218,500
-77,108
| -26% | -$274K |
|
2450
Trinity Industries
TRN
$2.36B
| $931K | ﹤0.01% |
+35,000
| New | +$841K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.